Literature DB >> 16203724

Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion.

Angela M Domitrovich1, Daniel J Felmlee, Aleem Siddiqui.   

Abstract

Host genes involved in lipid metabolism are differentially regulated during the early stages of hepatitis C virus (HCV) infection. The majority of lipids synthesized in the liver are exported to other tissues in the form of lipoproteins. The formation of these lipoproteins is dependent upon the association of triglycerides with apolipoprotein B100. Using the HCV subgenomic replicon expression system, we show that secretion of apoB100 is significantly reduced. Inhibition of apoB100 degradation by ALLN did not improve secretion. Triglyceride levels as well as microsomal triglyceride transfer protein mRNA and activity levels were reduced in replicon-expressing cells, indicating potential reasons for the observed decrease. Further evidence is presented for the interaction between the HCV nonstructural protein 5A and apoB100. These results provide further insight into the alteration of lipid metabolism by HCV.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16203724     DOI: 10.1074/jbc.M510391200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Investigation of plasma biomarkers in HIV-1/HCV mono- and coinfected individuals by multiplex iTRAQ quantitative proteomics.

Authors:  Vivekananda Shetty; Pooja Jain; Zacharie Nickens; Gomathinayagam Sinnathamby; Anand Mehta; Ramila Philip
Journal:  OMICS       Date:  2011-10

2.  Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans.

Authors:  Ke-Qin Hu; Sue L Currie; Hui Shen; Ramsey C Cheung; Samuel B Ho; Edmund J Bini; John D McCracken; Tim Morgan; Norbert Bräu; Warren N Schmidt; Lennox Jeffers; Teresa L Wright
Journal:  Dig Dis Sci       Date:  2007-01-17       Impact factor: 3.199

3.  Fatty liver in chronic hepatitis C infection: unravelling the mechanisms.

Authors:  Jude A Oben; Emma Paulon
Journal:  Gut       Date:  2007-09       Impact factor: 23.059

4.  Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins.

Authors:  Hua Huang; Fang Sun; David M Owen; Weiping Li; Yan Chen; Michael Gale; Jin Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-21       Impact factor: 11.205

5.  Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study.

Authors:  Jason Reingold; Christine Wanke; Donald Kotler; Cora Lewis; Russell Tracy; Steven Heymsfield; Phyllis Tien; Peter Bacchetti; Rebecca Scherzer; Carl Grunfeld; Michael Shlipak
Journal:  J Acquir Immune Defic Syndr       Date:  2008-06-01       Impact factor: 3.731

Review 6.  Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.

Authors:  Qing Liu; Stig Bengmark; Shen Qu
Journal:  BMC Gastroenterol       Date:  2010-05-20       Impact factor: 3.067

7.  Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP).

Authors:  Silvia Mirandola; David Bowman; Mahmood M Hussain; Alfredo Alberti
Journal:  Nutr Metab (Lond)       Date:  2010-02-23       Impact factor: 4.169

Review 8.  Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen.

Authors:  Amedeo Lonardo; Luigi Elio Adinolfi; Luciano Restivo; Stefano Ballestri; Dante Romagnoli; Enrica Baldelli; Fabio Nascimbeni; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

9.  Entry of hepatitis C virus into the cell: a therapeutic target.

Authors:  José Antonio Del Campo; Ángela Rojas; Manuel Romero-Gómez
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

10.  Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins.

Authors:  Vinca Icard; Olivier Diaz; Caroline Scholtes; Laure Perrin-Cocon; Christophe Ramière; Ralf Bartenschlager; Francois Penin; Vincent Lotteau; Patrice André
Journal:  PLoS One       Date:  2009-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.